Loading...
XHKG1951
Market cap988mUSD
Dec 27, Last price  
2.79HKD
1D
-2.45%
1Q
-10.86%
IPO
-68.08%
Name

Jinxin Fertility Group Ltd

Chart & Performance

D1W1MN
XHKG:1951 chart
P/E
20.93
P/S
2.59
EPS
0.13
Div Yield, %
0.14%
Shrs. gr., 5y
2.82%
Rev. gr., 5y
24.78%
Revenues
2.79b
+17.95%
346,408,000662,774,000921,994,0001,648,496,0001,426,088,0001,838,826,0002,364,479,0002,788,910,000
Net income
345m
+184.60%
87,584,00098,783,000166,600,000409,623,000251,622,000339,901,000121,124,000344,723,000
CFO
684m
+26.35%
108,982,00047,682,000356,437,000452,568,000308,039,000343,452,000541,740,000684,484,000
Dividend
Jun 27, 20240.0595 HKD/sh

Profile

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; medical services in the areas of gynecology, urology, and internal medicine; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, and real estate development and operation activities. Jinxin Fertility Group Limited was founded in 2003 and is headquartered in Chengdu, China.
URL
https://www.jxr-fertility.com/
IPO date
Jun 25, 2019
Employees
3,045
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
2,788,910
17.95%
2,364,479
28.59%
1,838,826
28.94%
Cost of revenue
2,308,436
2,079,113
1,467,441
Unusual Expense (Income)
NOPBT
480,474
285,366
371,385
NOPBT Margin
17.23%
12.07%
20.20%
Operating Taxes
117,285
36,375
104,230
Tax Rate
24.41%
12.75%
28.07%
NOPAT
363,189
248,991
267,155
Net income
344,723
184.60%
121,124
-64.36%
339,901
35.08%
Dividends
(10,504)
(158,676)
Dividend yield
0.11%
0.84%
Proceeds from repurchase of equity
999,586
583,698
1,014,657
BB yield
-10.91%
-3.08%
-4.65%
Debt
Debt current
976,641
1,717,933
99,926
Long-term debt
2,151,315
2,609,831
2,052,006
Deferred revenue
984,226
607,591
Other long-term liabilities
1,290,142
(2,170,589)
(1,618,932)
Net debt
2,003,480
2,795,519
(129,255)
Cash flow
Cash from operating activities
684,484
541,740
343,452
CAPEX
(173,568)
(959,393)
(79,833)
Cash from investing activities
(375,037)
(1,377,837)
(1,566,182)
Cash from financing activities
(950,449)
460,142
955,054
FCF
334,925
(1,353,203)
52,714
Balance
Cash
852,900
1,401,248
1,928,021
Long term investments
271,576
130,997
353,166
Excess cash
985,030
1,414,021
2,189,246
Stockholders' equity
1,935,916
1,329,979
1,322,831
Invested Capital
13,197,954
11,559,794
9,394,198
ROIC
2.93%
2.38%
3.29%
ROCE
3.39%
2.03%
3.17%
EV
Common stock shares outstanding
2,735,787
2,624,469
2,504,332
Price
3.35
-53.54%
7.21
-17.22%
8.71
-44.31%
Market cap
9,164,886
-51.57%
18,922,421
-13.25%
21,812,732
-42.27%
EV
11,655,760
22,286,287
22,351,923
EBITDA
765,202
546,760
541,007
EV/EBITDA
15.23
40.76
41.32
Interest
79,641
71,853
21,146
Interest/NOPBT
16.58%
25.18%
5.69%